PDSB icon

PDS Biotechnology

51 hedge funds and large institutions have $19.2M invested in PDS Biotechnology in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 12 closing their positions.

Holders
51
Holders Change
-1
Holders Change %
-1.92%
% of All Funds
0.86%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
13
Reduced
13
Closed
12
Calls
$2.64M
Puts
$978K
Net Calls
+$1.67M
Net Calls Change
-$563K
Name Holding Trade Value Shares
Change
Shares
Change %
Bank of Montreal
51
Bank of Montreal
Ontario, Canada
$249 +$249 +43,500 New
ACM
52
AIGH Capital Management
Maryland
-$1.75M -282,609 Closed
FAM
53
Fred Alger Management
New York
-$737K -119,082 Closed
D.E. Shaw & Co
54
D.E. Shaw & Co
New York
-$514K -83,112 Closed
WVP
55
Worth Venture Partners
New Jersey
-$436K -70,378 Closed
Goldman Sachs
56
Goldman Sachs
New York
-$184K -29,752 Closed
AA
57
ALPS Advisors
Colorado
-$181K -29,221 Closed
GCP
58
GSA Capital Partners
United Kingdom
-$89K -14,321 Closed
Qube Research & Technologies (QRT)
59
Qube Research & Technologies (QRT)
United Kingdom
-$86K -13,862 Closed
IC
60
Ikarian Capital
Texas
-$22K -3,672 Closed
UBS Group
61
UBS Group
Switzerland
-$15K -2,499 Closed
Rockefeller Capital Management
62
Rockefeller Capital Management
New York
-$5K -955 Closed
TRCT
63
Tower Research Capital (TRC)
New York
-$1K -124 Closed